Dynavax ended the fourth quarter with $189.4 million in cash, which, according to our model, should sustain operations into 2016.…
Browsing: Scientific Instruments
ExlService posted better-than-expected fourth-quarter results, delivering revenue of $124 million (above the consensus at $120 million) and non-GAAP earnings per…
Sonova Holding reported its first-half results for fiscal 2013 on Wednesday. For the first time in a while, currency positively…
Gartner announced the acquisition of Software Advice this morning. This is a relatively small acquisition, but because Gartner has not…
Monroe Capital’s net investment income of $0.31 exceeded our $0.28 forecast, primarily due a large prepayment fee, which more than…
After thoroughly reviewing the Muddy Waters document and speaking with American Tower’s management, Morningstar is reiterating the fair value estimate…
Novartis reported second-quarter results that largely matched expectations and those of consensus. No significant changes are made to the estimate…
AstraZeneca reported strong fourth-quarter results that exceeded both our expectations and those of consensus, partly driven by a low tax…
Pepco reported adjusted earnings per share of $0.22 for the second quarter of 2013 versus $0.20 in the same period…
Myriad Genetics reported fiscal fourth-quarter results and provided guidance for 2014 that were both ahead of expectations. Longer term, analysts…
Chorus reported a fiscal 2013 result in line with analyst’s expectations. Fiscal 2014 earnings before interest, tax, depreciation and amortisation,…
Diversified Restaurant Holdings (BAGR) reported in-line 4Q earnings, with same store sales growth of 10.3%, sending shares up 17%. Diversified,…